Bukwang Pharmaceutical バランスシートの健全性
財務の健全性 基準チェック /46
Bukwang Pharmaceutical has a total shareholder equity of ₩229.3B and total debt of ₩78.7B, which brings its debt-to-equity ratio to 34.3%. Its total assets and total liabilities are ₩349.2B and ₩119.9B respectively.
主要情報
34.3%
負債資本比率
₩78.75b
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | ₩109.21b |
| エクイティ | ₩229.26b |
| 負債合計 | ₩119.93b |
| 総資産 | ₩349.20b |
財務の健全性に関する最新情報
Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?
May 22
Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?
Feb 10Recent updates
Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?
May 22Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First
Apr 03Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?
Mar 08Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?
Feb 10How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?
Jan 14Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?
Dec 19Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?
Nov 23財務状況分析
短期負債: A003000's short term assets (₩191.0B) exceed its short term liabilities (₩29.4B).
長期負債: A003000's short term assets (₩191.0B) exceed its long term liabilities (₩90.6B).
デット・ツー・エクイティの歴史と分析
負債レベル: A003000 has more cash than its total debt.
負債の削減: A003000's debt to equity ratio has increased from 4% to 34.3% over the past 5 years.
債務返済能力: A003000's debt is well covered by operating cash flow (27.6%).
インタレストカバレッジ: Insufficient data to determine if A003000's interest payments on its debt are well covered by EBIT.